Found: 7
Select item for more details and to access through your institution.
Targeting Methylglyoxal in Diabetic Kidney Disease Using the Mitochondria-Targeted Compound MitoGamide.
- Published in:
- Nutrients, 2021, v. 13, n. 5, p. 1457, doi. 10.3390/nu13051457
- By:
- Publication type:
- Article
Targeted deletion of nicotinamide adenine dinucleotide phosphate oxidase 4 from proximal tubules is dispensable for diabetic kidney disease development.
- Published in:
- Nephrology Dialysis Transplantation, 2021, v. 36, n. 6, p. 988, doi. 10.1093/ndt/gfaa376
- By:
- Publication type:
- Article
Correction to: The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart.
- Published in:
- Cardiovascular Drugs & Therapy, 2019, v. 33, n. 6, p. 669, doi. 10.1007/s10557-019-06914-9
- By:
- Publication type:
- Article
Autism Under Age 3 Years: A Clinical Study of 28 Cases Referred for Autistic Symptoms in Infancy.
- Published in:
- Journal of Child Psychology, 1990, v. 31, n. 6, p. 921, doi. 10.1111/j.1469-7610.1990.tb00834.x
- By:
- Publication type:
- Article
The early life origin theory in the development of cardiovascular disease and type 2 diabetes.
- Published in:
- Molecular Biology Reports, 2015, v. 42, n. 4, p. 791, doi. 10.1007/s11033-014-3766-5
- By:
- Publication type:
- Article
Delineating a role for the mitochondrial permeability transition pore in diabetic kidney disease by targeting cyclophilin D.
- Published in:
- Clinical Science, 2020, v. 134, n. 2, p. 239, doi. 10.1042/CS20190787
- By:
- Publication type:
- Article